These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 22763379)

  • 1. MLH1 methylation screening is effective in identifying epimutation carriers.
    Pineda M; Mur P; Iniesta MD; Borràs E; Campos O; Vargas G; Iglesias S; Fernández A; Gruber SB; Lázaro C; Brunet J; Navarro M; Blanco I; Capellá G
    Eur J Hum Genet; 2012 Dec; 20(12):1256-64. PubMed ID: 22763379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De novo constitutional MLH1 epimutations confer early-onset colorectal cancer in two new sporadic Lynch syndrome cases, with derivation of the epimutation on the paternal allele in one.
    Goel A; Nguyen TP; Leung HC; Nagasaka T; Rhees J; Hotchkiss E; Arnold M; Banerji P; Koi M; Kwok CT; Packham D; Lipton L; Boland CR; Ward RL; Hitchins MP
    Int J Cancer; 2011 Feb; 128(4):869-78. PubMed ID: 20473912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of constitutional MLH1 epimutation associated to transgenerational inheritance of cancer susceptibility.
    Crépin M; Dieu MC; Lejeune S; Escande F; Boidin D; Porchet N; Morin G; Manouvrier S; Mathieu M; Buisine MP
    Hum Mutat; 2012 Jan; 33(1):180-8. PubMed ID: 21953887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MLH1 germline epimutations as a factor in hereditary nonpolyposis colorectal cancer.
    Hitchins M; Williams R; Cheong K; Halani N; Lin VA; Packham D; Ku S; Buckle A; Hawkins N; Burn J; Gallinger S; Goldblatt J; Kirk J; Tomlinson I; Scott R; Spigelman A; Suter C; Martin D; Suthers G; Ward R
    Gastroenterology; 2005 Nov; 129(5):1392-9. PubMed ID: 16285940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MLH1 constitutional and somatic methylation in patients with MLH1 negative tumors fulfilling the revised Bethesda criteria.
    Crucianelli F; Tricarico R; Turchetti D; Gorelli G; Gensini F; Sestini R; Giunti L; Pedroni M; Ponz de Leon M; Civitelli S; Genuardi M
    Epigenetics; 2014 Oct; 9(10):1431-8. PubMed ID: 25437057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The MLH1 c.-27C>A and c.85G>T variants are linked to dominantly inherited MLH1 epimutation and are borne on a European ancestral haplotype.
    Kwok CT; Vogelaar IP; van Zelst-Stams WA; Mensenkamp AR; Ligtenberg MJ; Rapkins RW; Ward RL; Chun N; Ford JM; Ladabaum U; McKinnon WC; Greenblatt MS; Hitchins MP
    Eur J Hum Genet; 2014 May; 22(5):617-24. PubMed ID: 24084575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Finding the needle in a haystack: identification of cases of Lynch syndrome with MLH1 epimutation.
    Hitchins MP
    Fam Cancer; 2016 Jul; 15(3):413-22. PubMed ID: 26886015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant mutation and epimutation of the MLH1 gene in a Lynch syndrome family.
    Cini G; Carnevali I; Quaia M; Chiaravalli AM; Sala P; Giacomini E; Maestro R; Tibiletti MG; Viel A
    Carcinogenesis; 2015 Apr; 36(4):452-8. PubMed ID: 25742745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of MLH1 constitutional epimutations as a cause of Lynch syndrome in unselected versus selected consecutive series of patients with colorectal cancer.
    Castillejo A; Hernández-Illán E; Rodriguez-Soler M; Pérez-Carbonell L; Egoavil C; Barberá VM; Castillejo MI; Guarinos C; Martínez-de-Dueñas E; Juan MJ; Sánchez-Heras AB; García-Casado Z; Ruiz-Ponte C; Brea-Fernández A; Juárez M; Bujanda L; Clofent J; Llor X; Andreu M; Castells A; Carracedo A; Alenda C; Payá A; Jover R; Soto JL
    J Med Genet; 2015 Jul; 52(7):498-502. PubMed ID: 25908759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diversity of genetic events associated with MLH1 promoter methylation in Lynch syndrome families with heritable constitutional epimutation.
    Leclerc J; Flament C; Lovecchio T; Delattre L; Ait Yahya E; Baert-Desurmont S; Burnichon N; Bronner M; Cabaret O; Lejeune S; Guimbaud R; Morin G; Mauillon J; Jonveaux P; Laurent-Puig P; Frébourg T; Porchet N; Buisine MP
    Genet Med; 2018 Dec; 20(12):1589-1599. PubMed ID: 29790873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of MLH1 constitutional methylation for Lynch syndrome diagnosis in patients with tumor MLH1 downregulation.
    Pinto D; Pinto C; Guerra J; Pinheiro M; Santos R; Vedeld HM; Yohannes Z; Peixoto A; Santos C; Pinto P; Lopes P; Lothe R; Lind GE; Henrique R; Teixeira MR
    Cancer Med; 2018 Feb; 7(2):433-444. PubMed ID: 29341452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of constitutional MLH1 epimutations and promoter variants in colorectal cancer patients from the Colon Cancer Family Registry.
    Ward RL; Dobbins T; Lindor NM; Rapkins RW; Hitchins MP
    Genet Med; 2013 Jan; 15(1):25-35. PubMed ID: 22878509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MLH1 promoter hypermethylation in the analytical algorithm of Lynch syndrome: a cost-effectiveness study.
    Gausachs M; Mur P; Corral J; Pineda M; González S; Benito L; Menéndez M; Espinàs JA; Brunet J; Iniesta MD; Gruber SB; Lázaro C; Blanco I; Capellá G
    Eur J Hum Genet; 2012 Jul; 20(7):762-8. PubMed ID: 22274583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of allelic imbalance in MLH1 expression by pyrosequencing serves as a tool for the identification of germline defects in Lynch syndrome.
    Kwok CT; Ward RL; Hawkins NJ; Hitchins MP
    Fam Cancer; 2010 Sep; 9(3):345-56. PubMed ID: 20063070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly sensitive MLH1 methylation analysis in blood identifies a cancer patient with low-level mosaic MLH1 epimutation.
    Dámaso E; Canet-Hermida J; Vargas-Parra G; Velasco À; Marín F; Darder E; Del Valle J; Fernández A; Izquierdo À; Mateu G; Oliveras G; Escribano C; Piñol V; Uchima HI; Soto JL; Hitchins M; Farrés R; Lázaro C; Queralt B; Brunet J; Capellá G; Pineda M
    Clin Epigenetics; 2019 Nov; 11(1):171. PubMed ID: 31779681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study.
    Goodfellow PJ; Billingsley CC; Lankes HA; Ali S; Cohn DE; Broaddus RJ; Ramirez N; Pritchard CC; Hampel H; Chassen AS; Simmons LV; Schmidt AP; Gao F; Brinton LA; Backes F; Landrum LM; Geller MA; DiSilvestro PA; Pearl ML; Lele SB; Powell MA; Zaino RJ; Mutch D
    J Clin Oncol; 2015 Dec; 33(36):4301-8. PubMed ID: 26552419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constitutional (germline) MLH1 epimutation as an aetiological mechanism for hereditary non-polyposis colorectal cancer.
    Hitchins MP; Ward RL
    J Med Genet; 2009 Dec; 46(12):793-802. PubMed ID: 19564652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour MLH1 promoter region methylation testing is an effective prescreen for Lynch Syndrome (HNPCC).
    Newton K; Jorgensen NM; Wallace AJ; Buchanan DD; Lalloo F; McMahon RF; Hill J; Evans DG
    J Med Genet; 2014 Dec; 51(12):789-96. PubMed ID: 25280751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of new cases of early-onset colorectal cancer with an MLH1 epimutation in an ethnically diverse South African cohort.
    Hitchins MP; Owens SE; Kwok CT; Godsmark G; Algar UF; Ramesar RS
    Clin Genet; 2011 Nov; 80(5):428-34. PubMed ID: 21375527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MLH1 germline epimutations in selected patients with early-onset non-polyposis colorectal cancer.
    Valle L; Carbonell P; Fernandez V; Dotor AM; Sanz M; Benitez J; Urioste M
    Clin Genet; 2007 Mar; 71(3):232-7. PubMed ID: 17309645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.